H.R. 1414

119th CongressIn committee

Cameron’s Law

Cameron’s Law

Sponsored by Josh Gottheimer (Democrat-NJ-5)

Civil Penalty Adjustments Tax Policy & Reform

Cosponsors

19

Actions

3

Roll calls

0

Amendments

0

Related bills

0

Actions

Feb 18, 2025 · Library of Congress

Introduced in House

Feb 18, 2025 · Library of Congress

Introduced in House

Feb 18, 2025 · House floor actions

Referred to the House Committee on Ways and Means.

Latest activity

Activity

July 2026

Lobbying reported · Alston & Bird · Jul 20

Alston & Bird reported 2nd Quarter (Apr 1 - June 30) lobbying for Travere Therapeutics — $70,000

BillsH.R. 1414 H.R. 1518

Lobbying reported · Soleno Therapeutics · Jul 20

Soleno Therapeutics reported 2nd Quarter (Apr 1 - June 30) lobbying for Soleno Therapeutics — $70,000

BillsH.R. 1414 H.R. 1492 H.R. 7118 S. 832

Lobbying reported · Astrazeneca Pharmaceuticals · Jul 20

Astrazeneca Pharmaceuticals reported 2nd Quarter (Apr 1 - June 30) lobbying for Astrazeneca Pharmaceuticals — $1,680,000

BillsH.R. 1414 H.R. 3521 H.R. 5509 H.R. 7118 H.R. 9599 S. 1637 S. 2903 S. 3841 S. 4440

Lobbying reported · Acadia Pharmaceuticals · Jul 20

Acadia Pharmaceuticals reported 2nd Quarter (Apr 1 - June 30) lobbying for Acadia Pharmaceuticals — $700,000

BillsH.R. 1 H.R. 1262 H.R. 1414 H.R. 1492 H.R. 1509 H.R. 3731 H.R. 6130 H.R. 9102 S. 752 S. 832 S. 932 S. 3267

Lobbying reported · Ptc Therapeutics · Jul 20

Ptc Therapeutics reported 2nd Quarter (Apr 1 - June 30) lobbying for Ptc Therapeutics — $170,000

BillsH.R. 1414 H.R. 1492

Lobbying reported · Harmony Biosciences · Jul 20

Harmony Biosciences reported 2nd Quarter (Apr 1 - June 30) lobbying for Harmony Biosciences — $180,000

BillsH.R. 1414 H.R. 1492 H.R. 1672 S. 832

Lobbying reported · Travere Therapeutics · Jul 20

Travere Therapeutics reported 2nd Quarter (Apr 1 - June 30) lobbying for Travere Therapeutics — $140,000

BillsH.R. 1 H.R. 1262 H.R. 1414 H.R. 1518 H.R. 4709 H.R. 9102 S. 932 S. 1040 S. 2658

Lobbying reported · Ionis Pharmaceuticals · Jul 17

Ionis Pharmaceuticals reported 2nd Quarter (Apr 1 - June 30) lobbying for Ionis Pharmaceuticals — $150,000

BillsH.R. 1262 H.R. 1414 H.R. 1672 S. 932

Lobbying reported · EveryLife Foundation for Rare Diseases · Jul 17

EveryLife Foundation for Rare Diseases reported 2nd Quarter (Apr 1 - June 30) lobbying for EveryLife Foundation for Rare Diseases — $40,000

BillsH.R. 1414 H.R. 4709 H.R. 5509 H.R. 7118 S. 2903

Lobbying reported · Rare Disease Company Coalition · Jul 16

Rare Disease Company Coalition reported 2nd Quarter (Apr 1 - June 30) lobbying for Rare Disease Company Coalition — $70,000

BillsH.R. 1 H.R. 1414 H.R. 7148

Lobbying reported · Vertex Pharmaceuticals · Jul 16

Vertex Pharmaceuticals reported 2nd Quarter (Apr 1 - June 30) lobbying for Vertex Pharmaceuticals — $1,200,000

BillsH.R. 1227 H.R. 1414 H.R. 1518 H.R. 6423 S. 475 S. 864

Lobbying reported · Healthcare Institute Of New Jersey · Jul 15

Healthcare Institute Of New Jersey reported 2nd Quarter (Apr 1 - June 30) lobbying for Healthcare Institute Of New Jersey — $47,670

BillsH.R. 1262 H.R. 1414 H.R. 1492 H.R. 1672 H.R. 2369 H.R. 2377 H.R. 2940 H.R. 5269 H.R. 5391 H.R. 6283 S. 832 S. 932 S. 2761 S. 3549

You’re all caught up.